The Horseracing Integrity and Safety Authority (HISA) has reappointed Jeff Novitzky, a seasoned figure in anti-doping enforcement, to its Anti-Doping and Medication Control (ADMC) Standing Committee. Known for his impactful career as both a sports executive and federal investigator, Novitzky brings extensive experience in drug-testing policies and fair competition practices. His background includes leading investigations into illegal performance-enhancing substances within professional sports, making him a pivotal asset to the committee's mission of promoting safety, transparency, and integrity in horse racing.

Jeff Novitzky, renowned for his work combating doping in sports, has been reinstated to HISA’s ADMC Standing Committee. As Senior Vice President of Anti-Doping Compliance for the Ultimate Fighting Championship (UFC), Novitzky plays a critical role in shaping the organization's drug-testing protocols. Before joining UFC in 2015, he served as a federal agent with the U.S. Food and Drug Administration’s office of criminal investigations. There, he spearheaded probes into companies distributing performance-enhancing drugs, including high-profile cases like Lance Armstrong's cycling scandal. Additionally, his tenure at the Internal Revenue Service involved investigating landmark anti-doping controversies such as those surrounding Barry Bonds and the Bay Area Laboratory Co-operative.

Charles Scheeler, chair of the ADMC standing committee and the HISA board of directors, emphasized Novitzky's invaluable expertise in reinforcing the committee's objectives. With Novitzky's leadership, the committee aims to enhance the development of comprehensive rules and protocols for the ADMC program. This includes refining the Prohibited Substances List, setting laboratory testing standards, and overseeing in-competition and out-of-competition testing programs. Furthermore, the committee is committed to advancing research and educational initiatives that support these efforts.

HISA also acknowledges the significant contributions of Dr. Jerry Yon, who recently retired from the committee after years of service. CEO Lisa Lazarus expressed gratitude for Dr. Yon's dedication, noting his crucial role in establishing the foundational framework of the ADMC Program. His legacy will continue to influence the sport's integrity and welfare. The daily operations of the ADMC program are overseen by the Horseracing Integrity & Welfare Unit, ensuring compliance with established medication rules while prioritizing the well-being of horses.

With Novitzky's return and the ongoing commitment of all committee members, HISA is poised to further strengthen its mission of upholding safety, fairness, and integrity in horse racing. This collaboration ensures that the sport continues to evolve responsibly, guided by robust policies and dedicated professionals.